Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

FLUIDIGM Patent Portfolio Analysis
May.2017

blockingpotentialoffluidigm_km
3 990 €

Choose a minimum of three reports from Yole Group and receive a discount of at least 39% on your package – Contact us!

 

Description

Yole Fluidigm Patent Portfolio Analysis May 2016 Report KM17005 Flye

Fluidigm is taking a leading IP position in emerging microfluidic technologies.

FLUIDIGM HAS BEEN HIGHLY INNOVATIVE SINCE THE EARLY 2000s

The microfluidics device market is currently growing, with a wide scope of applications across many industries. According to our partner Yole Développement, the microfluidics device market is worth $2.5 billion in 2017. With an expected compound annual growth rate of 18%, this market is projected to reach $5.8 billion by 2022. This high growth rate is largely due to advances in biotechnology, including gene sequencing and genomics. FLUIDIGM is considered as a pioneer in these microfluidic technologies. FLUIDIGM was founded in 1999 to market the integrated fluidic circuit based on a pneumatic rubber valve developed in the laboratory of Stephen Quake, then at Caltech. With this technology, FLUIDIGM became the first company to commercialize a digital polymerase chain reaction (PCR) product in 2006. In 2009, FLUIDIGM was described as "the world's leading manufacturer of microfluidic devices" by the Nanotechnology Business Journal. Today, among the applications in which FLUIDIGM products are put to use are single-cell genomics, gene expression, single nucleotide polymorphism (SNP) genotyping, targeted resequencing, sample quantitation, copy number variation and mass cytometry.

TimeEvolutionFluidigm Patent Portfolio KM
FLUIDIGM started developing its patent portfolio in the early 2000s and the number of new patents filed each year by FLUIDIGM has remained stable since then. Moreover, FLUIDIGM acquired numerous patents from HELICOS BIOSCIENCES, DVS SCIENCES and ARCXIS BIOTECHNOLOGIES. In recent years, FLUIDIGM’s total revenue has decreased. This decline in revenue was partly due to lower sales for genomic products. Therefore, in order to find new growth engines, technologies patented by FLUIDIGM have evolved considerably since its inception. This technological diversification exposes FLUIDIGM to new competitors, especially some big patent assignees that may assert their patents and other proprietary rights against FLUIDIGM.

 

CITATION NETWORK AND COMPETITIVE IP ENVIRONMENT

FLUIDIGM’s patent portfolio has been cited by more than 700 patent assignees in more than 2300 patent families. For its part, FLUIDIGM cites 2600 patent families in its portfolio, representing around 900 assignees.

Combining the citation network with the analysis of the content of citing/cited patents, FLUIDIGM’s IP competitors have been ranked in order to establish a general view of the competitive IP environment. Thus IP competitors developing microfluidic technologies have been identified for various applications such as protein crystallization, next-generation sequencing (NGS) and digital PCR, single cell genomics or mass cytometry.

CitationNetworkofFluidigm KM 

IDENTIFY BLOCKING PATENTS

Analyzing citations and citing applicants, FLUIDIGM’s patents with a high potential for IP blocking of other patent applicants in the field of microfluidics have been identified. Most of those patents are related to single cell analysis or digital PCR. Several of these patents were acquired by FLUIDIGM from other companies, or co-filed with academics. The IP blocking power of product categories and applications claimed by FLUIDIGM was also analyzed.

BlockingPOtentialofFluidigm KM

 

IDENTIFY KEY PATENTS

Key patents have been identified based on several indicators, including family size, legal status, citation analysis and impact on microfluidic technology. Newly granted patents, recently expired patents and patents expiring in the next few years have also been analyzed. Several patents were granted recently in the USA, Europe and China, in particular in the field of mass cytometry.
This report also includes an Excel database containing all of the analyzed patents. This database allows for multi-criteria searches and includes patent publication number, hyperlinks to the original documents, priority date, title, abstract, patent assignees and legal status for each member of the patent family.

GrantedPatentsExpired KM

ASSIGNEES CITED IN THE REPORT INCLUDE:

3M, ABBOTT, AFFYMETRIX, AGENA BIOSCIENCE, AGILENT TECHNOLOGIES, ARCXIS BIOTECHNOLOGIES, BD, BECKMAN COULTER, BIO-RAD, CALIPER, CALTECH, COMPLETE GENOMICS, DOW, DVS SCIENCES, FLUIDIGM, GE HEALTHCARE, GPB SCIENTIFIC, HANDYLAB, HELICOS BIOSCIENCES, HITACHI, HYALOS THERAPEUTICS, IBM, ILLUMINA, INTEGENX, LECO, LGC, LIFE TECHNOLOGIES, LUMINEX, NATERA, OPKO, PACIFIC BIOSCIENCES, PERKINELMER, PHILIPS, QUANTERIX, RAINDANCE, ROCHE, SEQLL, SEQUENOM, SHIMADZU, SIEMENS, SONY, THERMO FISHER SCIENTIFIC, UNIVERSITY OF BRITISH COLUMBIA, UNIVERSITY OF CALIFORNIA, UNIVERSTY OF CALIFORNIA...

 

OBJECTIVES OF THE REPORT:

  • Understand the IP strategy of FLUIDIGM
  • Understand the competitive IP Environment of FLUIDIGM
  • Classify FLUIDIGM’s patents by their technical issue as well as their IP blocking potential for other IP players
  • Identify key patents
  • Identify recent granted patents, expired patents and granted patents near expiration

 

 

Table of contents

Introduction 5


> Scope of the Report 6
> Key Features of the Report 7
> Objectives of the Report 8
> Key Features of the Report 9
> Main Patent Assignees Mentioned In the Report 10
> Terminology for Patent Analysis 11

 

 

Methodology 13


> Methodology for Patent Search, Selection and Analysis 14
> Key Patents Analysis 16

 

 

FLUIDIGM IP Profile  16


> Company Presentation 18

> Patent Portfolio Composition 19
> Patent Portfolio – Main Acquisition: HELICOS BIOSCIENCES 20
> Patent Portfolio – Main Acquisition: DVS SCIENCES 21
> Patent Portfolio – Main Acquisition: ARCXIS BIOTECHNOLOGIES 22
> Time Evolution of Patent Publications 23
> Timeline of Countries of Publication 24
> Mapping of Granted Patents and Pending Patent Applications 25
> Main IP Representatives 26
> Main Inventors and Collaborations 27
> Timeline of the Contribution of Main Inventors 28
> Main IP Collaboration 29
> Main Cited Patent Families 30
> IP Blocking Potential of Most Cited Patent Families 31
> Forward Citations Timeline 32
> Citation Network 33
> Competitive IP Environment 34

 

 

 

Segmentation by product 35


> Segmentation by Product 36
> Timeline of the Product Segmentation 37
> Current Legal Status of Patents 38
> Granted Patents and Pending Applications Analysis 39
> Main Inventors 40
> IP Blocking Potential by Product Segment 41
> Citation Network 42
> Competitive IP Environment 43
> Key Patents 44

 

 

Segmentation by appication 45


> Segmentation by Application 46
> Timeline of the Application Segmentation 47
> Current Legal Status of Patents 48
> Granted Patents and Pending Applications 49
> Main Inventors 50
> IP Blocking Potential by Application 51
> Citation Network 52
> Competitive IP Environment 53
> Key Patents 54

 

 

License agreements 56


> Terminated License Agreements 57
> License Agreements In Progress 58

 

 

New granted patents  62


 

 

Granted patents recently lapsed/expired 70


 

 

Granted patents expiring between 2018 & 2019 - 74


 

 

Conclusion  79


> Conclusion 80

> Patent Portfolio Summary 81
> SWOT Matrix 82

 

 

About the authors

Knowmade is a Patent, Technology and Strategy consulting company involved in Microelectronics, Nanotechnology, Biotechnology and Life Sciences.

 

We provide Patent Search, Patent Landscape, Patent Analysis, Scientific Landscape, State of the Art, Technology Scouting, Technology Tracking, Alerts and Updates.

 

Our service offer consists of standard reports, custom studies & on-demand tracking, strategy consulting and training.

 

We combine information search services, scientific expertise, powerful analytics and visualization tools, and proprietary methodologies for analyzing patents and scientific information.

 

Knowmade supports research laboratories, industrial companies and investors in their business development.

 

http://www.knowmade.fr 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KEY FEATURES OF THE REPORT

  • Time evolution of patent publications and countries of patent filings

  • Current legal status of patents

  • Citation network, IP collaboration and competitive networks

  • Inventor identification

  • Key patent analysis

  • Patents recently expired

  • Granted patents near expiration

  • An extensive Excel database with all patents analyzed in the study.